Daily Dose: Late Start for Statins Still a Win?
A daily dose of clinical news on Patient Care you may have missed.
Wegovy Keeps Winning; Bye-bye Baby Blues; SPRITE After Menopause; +2: The Five for Friday
Antiobesity drug reduces CVD risk; postpartum depression Rx approved; sugary drinks up adverse hepatic events in older women; cuff size does matter, more.
Daily Sugared Drink Consumption May Increase Risk of Hepatic Morbidity, Mortality in Older Women
Postmenopausal women who consumed 1 or more sugary drinks daily had a nearly 2-fold increased risk of liver cancer in a study of more than 98 000.
Primary Care Management of Headache: Part 2
An overview of oral preventive medication options for migraine for primary care clinicians, here.
Prescription "Weight Loss" Drugs: Americans Voice an Opinion
Most Americans are aware of the hot prescription drugs associated with weight loss and many are interested in using them. But access and administration are problematic.
Daily Dose: Atogepant Associated with Reduction in Monthly Migraine Days
New Data Reveal How COVID-19 Vaccination Can Decrease Severity, Mortality Following SARS-CoV-2 Infection
Findings from a new study show the long-term benefits of COVID-19 vaccination to reduce inflammation after a breakthrough infection, say researchers.
5 Questions on CDC Updates to COVID-19 and Flu Vaccine Guidance
Updates to CDC recommendations on influenza and COVID-19 vaccines and vaccine formulations will impact your choices during flu season this year.
Antiobesity Medications Would be Covered by Medicare Under the "Treat and Reduce Obesity Act"
Role of Heavy Menstrual Bleeding in Iron Deficiency Anemia Overlooked, Expert Says
The symptom of HMB may be present in up to 50% of reproductive-aged girls and women, most of whom may not even realize that what they are experiencing is abnormal.
Expert Details the Top 3 CV Complications Seen in Patients with Obesity
Internist and obesity medicine specialist Alina Elperin, MD, details the most common cardiovascular complications that she has observed in patients with obesity.
Updated CDC Immunization Guidelines for 2023-2024 Tripledemic Viruses
CDC immunization recommendations for influenza, COVID-19, and RSV from the updated 2023 schedules are summarized in this Guideline Topline.
Daily Dose: Moderna, Pfizer COVID-19 Vaccines go Head-to-Head in Safety Study
Antiobesity Medication Semaglutide 2.4 mg Reduced Risk of MACE by 20%: Topline Results from Landmark SELECT Trial
The reduction in risk of CV events, the first to be shown by an antiobesity drug, was higher than expected and could help alter perceptions of the agents as "lifestyle drugs."
For Accurate BP Measurement, Cuff Size Must Be "Just Right"
Blood pressure cuffs that are too large or too small for an individual's upper arm return measurements that may misguide therapeutic decisions, say study authors.
Flu Shots for Your Patients Aged ≥65 Years: 2 Questions
Which influenza vaccines does CDC recommend for older adults and how do the recommended shots differ from the others available? A short quiz.
Climate Change, Power Outages, and Vaccines—Oh No!
You have tens of thousands of dollars worth of vaccines in your office fridge; your area loses power for 5 days after flooding rain. Now what?
Daily Dose: Majority of US Adults with HTN or T2D with Albuminuria go Undetected
Screen Patients with Obesity for These 2 CVD Risk Factors, Says One Expert
Obesity medicine specialist and internist Alina Elperin, MD, shares why screening for obstructive sleep apnea and metabolic disease in patients with obesity is crucial.
Atogepant Reduces Monthly Migraine Days vs Placebo in Persons with Chronic Migraine
The oral gepant reduced monthly migraine days as well as mean monthly use of migraine rescue medication.
